sb 203580 has been researched along with alpha-linolenic acid in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (alpha-linolenic acid) | Trials (alpha-linolenic acid) | Recent Studies (post-2010) (alpha-linolenic acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 3,275 | 293 | 1,466 |
| Protein | Taxonomy | sb 203580 (IC50) | alpha-linolenic acid (IC50) |
|---|---|---|---|
| cysteine protease ATG4B isoform a | Homo sapiens (human) | 15.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hennig, B; Lim, EJ; Toborek, M; Wang, L | 1 |
1 other study(ies) available for sb 203580 and alpha-linolenic acid
| Article | Year |
|---|---|
The role of fatty acids and caveolin-1 in tumor necrosis factor alpha-induced endothelial cell activation.
Topics: alpha-Linolenic Acid; Animals; Caveolae; Caveolin 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprostone; Endothelial Cells; Enzyme Activation; Imidazoles; Linoleic Acid; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Pyridines; Receptors, Tumor Necrosis Factor, Type I; RNA, Small Interfering; Swine; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |